Pathogenic (homozygous or compound heterozygous) mutations in LARS2 are associated with deafness and ovarian disgenesis, called Perrault syndrome-4 (PRLTS4). In some cases, people with certain pathogenic (compound heterozygous) mutations suffer from more severe symptoms starting in the womb such as anemia and hydrops (fluid build-up), and breathing difficulties after birth which can lead to death. This more severe syndrome is called hydrops, lactic acidosis, and sideroblastic anemia (HLASA)